About US
Contact us
>>Back
Takeda's Velcade successor gets quick FDA approval
- Publisher：
- Publication：2015/11/23
Just a couple of months after accepting the application, the FDA has approvedTakeda Pharmaceutical's Ninlaro, a treatment for multiple myeloma that the Japanese company hopes can get established before its blockbuster Velcadeloses patent protection. That will come sooner rather than later after a federal court ruling in August which could allow generics to hit in 2017, instead of 2022.